1 Haugen BR,Alexander EK,Bible KC,et al.2015 American thyroid association management guidelines or adult patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133. 2 Zehnder AM,Swift LA,Sundaram A,et al.Clinical features,treatment,and outcomes of cutaneous and oral squamous cell carcinoma in avian species[J].J Am Vet Med Assoc,2018,252(3):309-315. 3 Pitoia F,Jerkovich F.Selective use of sorafenib in the treatment ofthyroid cancer[J].Drug Des Dev Ther,2016,10:1119-1131. 4 Schlumberger M,Tahara M,Wirth LJ,et al.Lenvatinib versus placebo in radioiodine-refractory thyroid cancer[J].N Engl J Med,2015,12,372(7):621-630. 5 Ghosh RD,Ghuwalewala S,Das P,et al.MicroRNA profiling of cisplatin-resistant oralsquamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features[J].Sci Rep,2016,6:23932. 6 Dewan MZ,Galloway AE,Kawashima N,et al.Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal efect when combined with anti-CTLA-4 antibody[J].Clin.Cancer Res,2009,15(17):5379-5388. 7 Zhao D,Jin X,Li F,et al.Integrin αvβ3 imaging of radioactive iodine-refractory thyroid cancer using 99mTc-3PRGD2[J].J Nucl Med,2012,53(12):1872-1877. 8 Li Q,Zhang Y,Elnaggar AK,et al.Therapeutic efficacy of p53 restoration in mdm2-overexpressing tumors[J].Molecular Cancer Research Mcr,2014,12(6):901-911. 9 Jing FJ,Liang J,Liang ZY,et al.BRAFV600E mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma[J].Chin Med J,2013,126(16):3013-3018. 10 Durante C,Hanndy N,Baudin E,et al.Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma:benefits and limits of radioiodine therapy[J].J Clin Endocrinol Metab,2006,91(8):2892-2899. 11 Demaria S,Ng B,Devitt M,et al.Ionizing radiation inhibition of distant untreated tumors(abscopal efect)is immune mediated[J].Int.J.Radiat.Oncol,2004,58(3):862-870. 12 赵倩妤,孙轶华.拉曼光谱在癌症组织学诊断中的研究进展[J].实用肿瘤学杂志,2018,32(1):92-96. 13 Li J,Qin S,Xu J,et al.Randomized,double-blind,placebo-controlled phase Ⅲ trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction[J].J Clin Oncol,2016,34(13):1448-1454. 14 Schlumberger M,Brose M,Eliset R,et al.Definition and management of radioactive iodine-refractory differentiated thyroid cancer[J].Lancet Diabetes Endocrinol,2014,2(5):356-358. 15 Wiegering A,Korb D,Thalheimer A,et al.E7080(Lenvatinib),a multi-targeted tyrosine kinase inhibitor,demonstrates antitumor activities against colorectal cancer xenografts[J].Neoplasia,2014,16(11):972-981. 16 Tuttle RM.Risk-adapted management of thyroid cancer[J].Endocr Pract,2008,14(6):764-774. |